(2R,3S,4S,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Term ID

CHEBI:151703

Synonyms

alpha-D-manno-hexopyranosyl-(1->4)-alpha-D-manno-hexopyranosyl-(1->4)-D-manno-hexopyranose
Man(a1-4)Man(a1-4)Man
WURCS=2.0/2,3,2/[a1122h-1x_1-5][a1122h-1a_1-5]/1-2-2/a4-b1_b4-c1

Definition

References

GlyGen:G53162CM
GlyTouCan:G53162CM

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3S,4S,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype where environments contain (2R,3S,4S,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3S,4S,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype affecting (2R,3S,4S,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Human Disease Model